This is a firm-fixed-price purchase order awarded by the Department of the Army Medical Command to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies and multiplex diagnostic solutions. The contract is for $128,757.86 and the period of performance is through October 13, 2017. The contract is not designated as a set-aside. Luminex provides immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The $70,940.00 contract is to provide unspecified products and services related to the agency's medical research and clinical testing programs. This award does not have a set-aside designation. Luminex has previously been issued task orders under various government-wide acquisition vehicles and has served as a subcontractor...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The $7,150.00 order is for the provision of Luminex's 100/200 testing platform, which supports automated analysis of multiple biomarkers. This award falls under a larger indefinite delivery vehicle and is not set-aside. Luminex has a history of providing multiplex diagnostic solutions, assay kits, reagents,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
This is a $6,613.94 firm fixed-price purchase order awarded to Luminex Corp by a U.S. government agency. The contract is described as "DEOBLIGATE UNDELIVERED AMOUNT" and did not utilize a set-aside. Luminex Corp is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and has provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies. While Luminex...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The $50,490.00 contract is for INTELIFLEX-SERVICE-IMMUN and has an ultimate completion date of May 7, 2025. Luminex is the prime contractor and has not received a small business set-aside designation. Luminex is a supplier of specialized diagnostic products, testing platforms, reagents, and assay...
This is a $23,850 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of LUMINEX 200 SERVICE, with a period of performance through July 2027. Luminex Corporation is the prime contractor and holds several significant federal contract vehicles with the USDA and Department of Veterans Affairs for its specialized...
This is a $19,553.85 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Luminex Corp, a for-profit manufacturer of biological testing equipment and diagnostic solutions. The service level agreement contract is for the delivery of Luminex's proprietary multiplexing systems, assay kits, reagents, and related products to support clinical testing programs and biomedical research efforts across federal agencies....
This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...